Hydroxychloroquine is protective to the heart, not harmful: A systematic review

DOI record: { "DOI": "10.1016/j.nmni.2020.100747", "ISSN": [ "2052-2975" ], "URL": "http://dx.doi.org/10.1016/j.nmni.2020.100747", "alternative-id": [ "S2052297520300998" ], "article-number": "100747", "author": [ { "affiliation": [], "family": "Prodromos", "given": "C.C.", "sequence": "first" }, { "affiliation": [], "family": "Rumschlag", "given": "T.", "sequence": "additional" }, { "affiliation": [], "family": "Perchyk", "given": "T.", "sequence": "additional" } ], "container-title": "New Microbes and New Infections", "container-title-short": "New Microbes and New Infections", "content-domain": { "crossmark-restriction": false, "domain": [] }, "created": { "date-parts": [ [ 2020, 8, 20 ] ], "date-time": "2020-08-20T06:47:02Z", "timestamp": 1597906022000 }, "deposited": { "date-parts": [ [ 2020, 10, 9 ] ], "date-time": "2020-10-09T00:04:48Z", "timestamp": 1602201888000 }, "indexed": { "date-parts": [ [ 2024, 2, 8 ] ], "date-time": "2024-02-08T18:00:43Z", "timestamp": 1707415243619 }, "is-referenced-by-count": 13, "issued": { "date-parts": [ [ 2020, 9 ] ] }, "language": "en", "license": [ { "URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2020, 9, 1 ] ], "date-time": "2020-09-01T00:00:00Z", "timestamp": 1598918400000 } }, { "URL": "http://creativecommons.org/licenses/by-nc-nd/4.0/", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2020, 8, 19 ] ], "date-time": "2020-08-19T00:00:00Z", "timestamp": 1597795200000 } } ], "link": [ { "URL": "https://api.elsevier.com/content/article/PII:S2052297520300998?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://api.elsevier.com/content/article/PII:S2052297520300998?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining" } ], "member": "78", "original-title": [], "page": "100747", "prefix": "10.1016", "published": { "date-parts": [ [ 2020, 9 ] ] }, "published-print": { "date-parts": [ [ 2020, 9 ] ] }, "publisher": "Elsevier BV", "reference": [ { "article-title": "[A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19]", "author": "Chen", "first-page": "215", "journal-title": "Zhejiang Da Xue Xue Bao Yi Xue Ban", "key": "10.1016/j.nmni.2020.100747_bib1", "volume": "49", "year": "2020" }, { "DOI": "10.1016/j.tmaid.2020.101738", "article-title": "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: a retrospective analysis of 1061 cases in Marseille, France", "author": "Million", "doi-asserted-by": "crossref", "first-page": "101738", "journal-title": "Travel Med Infect Dis", "key": "10.1016/j.nmni.2020.100747_bib2", "volume": "35", "year": "2020" }, { "author": "Yu", "key": "10.1016/j.nmni.2020.100747_bib3", "series-title": "Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19", "year": "2020" }, { "author": "Olding", "key": "10.1016/j.nmni.2020.100747_bib4", "series-title": "Controversial doc in Trump’s ear calls malaria drug study ‘garbage.’ Daily Beast", "year": "2020" }, { "DOI": "10.1016/j.jaad.2020.04.031", "article-title": "Does hydroxychloroquine combat COVID-19? A timeline of evidence", "author": "Alia", "doi-asserted-by": "crossref", "first-page": "e33", "journal-title": "J Am Acad Dermatol", "key": "10.1016/j.nmni.2020.100747_bib5", "volume": "83", "year": "2020" }, { "DOI": "10.1111/acem.14005", "article-title": "A rapid systematic review of clinical trials utilizing chloroquine and hydroxychloroquine as a treatment for COVID-19", "author": "Chowdhury", "doi-asserted-by": "crossref", "first-page": "493", "journal-title": "Acad Emerg Med", "key": "10.1016/j.nmni.2020.100747_bib6", "volume": "27", "year": "2020" }, { "DOI": "10.1093/ofid/ofaa130", "article-title": "Review: hydroxychloroquine and chloroquine for treatment of SARS-CoV-2 (COVID-19)", "author": "Pastick", "doi-asserted-by": "crossref", "journal-title": "Open Forum Infect Dis", "key": "10.1016/j.nmni.2020.100747_bib7", "volume": "7", "year": "2020" }, { "key": "10.1016/j.nmni.2020.100747_bib10", "series-title": "Caution recommended on COVID-19 treatment with hydroxychloroquine and azithromycin for patients with cardiovascular disease", "year": "2020" }, { "DOI": "10.1136/annrheumdis-2019-215089", "article-title": "2019 update of the EULAR recommendations for the management of systemic lupus erythematosus", "author": "Fanouriakis", "doi-asserted-by": "crossref", "first-page": "736", "journal-title": "Ann Rheum Dis", "key": "10.1016/j.nmni.2020.100747_bib12", "volume": "78", "year": "2019" }, { "author": "Sullivan", "key": "10.1016/j.nmni.2020.100747_bib13", "series-title": "Ohio pharmacy board restricts prescriptions for experimental coronavirus treatment drugs. Columbus (Ohio) Dispatch", "year": "2020" }, { "DOI": "10.1097/RHU.0b013e31826852db", "article-title": "Fatal antimalarial-induced cardiomyopathy: report of 2 cases", "author": "Azimian", "doi-asserted-by": "crossref", "first-page": "363", "journal-title": "J Clin Rheumatol", "key": "10.1016/j.nmni.2020.100747_bib14", "volume": "18", "year": "2012" }, { "DOI": "10.1016/j.semarthrit.2003.09.012", "article-title": "Hydroxychloroquine cardiotoxicity in systemic lupus erythematosus: a report of 2 cases and review of the literature", "author": "Nord", "doi-asserted-by": "crossref", "first-page": "336", "journal-title": "Semin Arthritis Rheum", "key": "10.1016/j.nmni.2020.100747_bib15", "volume": "33", "year": "2004" }, { "DOI": "10.1097/RHU.0b013e31829d5e50", "article-title": "Suspected hydroxychloroquine-associated QT-interval prolongation in a patient with systemic lupus erythematosus", "author": "Morgan", "doi-asserted-by": "crossref", "first-page": "286", "journal-title": "J Clin Rheumatol", "key": "10.1016/j.nmni.2020.100747_bib16", "volume": "19", "year": "2013" }, { "article-title": "Life threatening severe QTc prolongation in patient with systemic lupus erythematosus due to hydroxychloroquine", "author": "O’Laughlin", "first-page": "4626279", "journal-title": "Case Rep Cardiol", "key": "10.1016/j.nmni.2020.100747_bib17", "volume": "2016", "year": "2016" }, { "DOI": "10.1080/15563650500514558", "article-title": "Chronic hydroxychloroquine use associated with QT prolongation and refractory ventricular arrhythmia", "author": "Chen", "doi-asserted-by": "crossref", "first-page": "173", "journal-title": "Clin Toxicol (Phila)", "key": "10.1016/j.nmni.2020.100747_bib18", "volume": "44", "year": "2006" }, { "DOI": "10.4269/ajtmh.20-0376", "article-title": "Case report: right bundle brunch block and QTc prolongation in a patient with novel coronavirus disease (COVID-19) treated with hydroxychloroquine", "author": "Asli", "doi-asserted-by": "crossref", "first-page": "79", "journal-title": "Am J Trop Med Hyg", "key": "10.1016/j.nmni.2020.100747_bib19", "volume": "103", "year": "2020" }, { "DOI": "10.1093/rheumatology/41.8.924", "article-title": "A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome", "author": "Erkan", "doi-asserted-by": "crossref", "first-page": "924", "journal-title": "Rheumatology (Oxford)", "key": "10.1016/j.nmni.2020.100747_bib20", "volume": "41", "year": "2002" }, { "DOI": "10.1161/CIRCULATIONAHA.111.089268", "article-title": "Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody–associated cardiac manifestations of neonatal lupus", "author": "Izmirly", "doi-asserted-by": "crossref", "first-page": "76", "journal-title": "Circulation", "key": "10.1016/j.nmni.2020.100747_bib21", "volume": "126", "year": "2012" }, { "DOI": "10.1016/0002-9343(94)90151-1", "article-title": "Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis", "author": "Petri", "doi-asserted-by": "crossref", "first-page": "254", "journal-title": "Am J Med", "key": "10.1016/j.nmni.2020.100747_bib22", "volume": "96", "year": "1994" }, { "DOI": "10.1111/ijcp.13095", "article-title": "Hydroxychloroquine may be associated with reduced risk of coronary artery diseases in patients with rheumatoid arthritis: a nationwide population-based cohort study", "author": "Hung", "doi-asserted-by": "crossref", "journal-title": "Int J Clin Pract", "key": "10.1016/j.nmni.2020.100747_bib23", "volume": "72", "year": "2018" }, { "article-title": "Hydroxychloroquine blood levels and risk of thrombotic events in systemic lupus erythematosus", "author": "Konig", "key": "10.1016/j.nmni.2020.100747_bib24", "series-title": "Paper presented at: 2019 American college of Rheumatology (ACR)/Association of Rheumatology professionals (ARP) annual meeting; 8–13 November 2019; Atlanta, GA. Abstract 2783", "year": "2019" }, { "DOI": "10.1177/0961203306071872", "article-title": "Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus", "author": "Ruiz-Irastorza", "doi-asserted-by": "crossref", "first-page": "577", "journal-title": "Lupus", "key": "10.1016/j.nmni.2020.100747_bib25", "volume": "15", "year": "2006" }, { "DOI": "10.1111/j.1753-5174.2009.00019.x", "article-title": "Drugs used in the treatment of rheumatoid arthritis: relationship between current use and cardiovascular risk factors", "author": "Rho", "doi-asserted-by": "crossref", "first-page": "34", "journal-title": "Arch Drug Inf", "key": "10.1016/j.nmni.2020.100747_bib26", "volume": "2", "year": "2009" }, { "DOI": "10.1002/cpt.1968", "article-title": "QT interval prolongation under hydroxychloroquine/azithromycin association for inpatients with SARS-CoV-2 lower respiratory tract infection", "author": "Bun", "doi-asserted-by": "crossref", "journal-title": "Clin Pharmacol Ther", "key": "10.1016/j.nmni.2020.100747_bib27", "year": "2020" }, { "DOI": "10.1161/CIRCEP.120.008662", "article-title": "The effect of chloroquine, hydroxychloroquine and azithromycin on the corrected QT interval in patients with SARS-CoV-2 infection", "author": "Saleh", "doi-asserted-by": "crossref", "journal-title": "Circ Arrhythm Electrophysiol", "key": "10.1016/j.nmni.2020.100747_bib28", "volume": "13", "year": "2020" }, { "DOI": "10.1186/ar2045", "article-title": "Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study", "author": "Van Halm", "doi-asserted-by": "crossref", "first-page": "R151", "journal-title": "Arthritis Res Ther", "key": "10.1016/j.nmni.2020.100747_bib29", "volume": "8", "year": "2006" }, { "article-title": "Hydroxychloroquine use is associated with decreased incident cardiovascular events in rheumatoid arthritis patients", "author": "Sharma", "journal-title": "J Am Heart Assoc", "key": "10.1016/j.nmni.2020.100747_bib30", "volume": "5", "year": "2016" }, { "article-title": "Long-term hydroxychloroquine therapy and risk of coronary artery disease in patients with systemic lupus erythematosus", "author": "Yang", "first-page": "796", "journal-title": "J Clin Med", "key": "10.1016/j.nmni.2020.100747_bib31", "volume": "8", "year": "2019" }, { "DOI": "10.18632/oncotarget.23570", "article-title": "The association between hydroxychloroquine treatment and cardiovascular morbidity among rheumatoid arthritis patients", "author": "Shapiro", "doi-asserted-by": "crossref", "first-page": "6615", "journal-title": "Oncotarget", "key": "10.1016/j.nmni.2020.100747_bib32", "volume": "9", "year": "2017" }, { "article-title": "Association of hydroxychloroquine use and incident atrial fibrillation in systemic lupus erythematosus: a retrospective study", "author": "Gupta", "key": "10.1016/j.nmni.2020.100747_bib33", "series-title": "Paper presented at: 2018 American College of Rheumatology (ACR)/Association of Rheumatology Professionals (ARP) annual meeting; 19–24 October 2018; Chicago, IL. Abstract 2670", "year": "2018" }, { "DOI": "10.1001/jamacardio.2020.1834", "article-title": "Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19)", "author": "Mercuro", "doi-asserted-by": "crossref", "journal-title": "JAMA Cardiol", "key": "10.1016/j.nmni.2020.100747_bib34", "year": "2020" }, { "DOI": "10.1016/j.hrthm.2020.06.029", "article-title": "Effects of hydroxychloroquine treatment on QT interval", "author": "Hooks", "doi-asserted-by": "crossref", "journal-title": "Heart Rhythm", "key": "10.1016/j.nmni.2020.100747_bib35", "year": "2020" }, { "DOI": "10.1016/j.hrthm.2020.05.014", "article-title": "QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin", "author": "Chorin", "doi-asserted-by": "crossref", "journal-title": "Heart Rhythm", "key": "10.1016/j.nmni.2020.100747_bib36", "year": "2020" }, { "DOI": "10.2147/DDDT.S166893", "article-title": "Chloroquine and hydroxychloroquine are associated with reduced cardiovascular risk: a systematic review and meta-analysis", "author": "Liu", "doi-asserted-by": "crossref", "first-page": "1685", "journal-title": "Drug Des Devel Ther", "key": "10.1016/j.nmni.2020.100747_bib37", "volume": "12", "year": "2018" }, { "DOI": "10.1136/annrheumdis-2017-211836", "article-title": "Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis", "author": "Rempenault", "doi-asserted-by": "crossref", "first-page": "98", "journal-title": "Ann Rheum Dis", "key": "10.1016/j.nmni.2020.100747_bib38", "volume": "77", "year": "2018" }, { "DOI": "10.1136/annrheumdis-2017-212571", "article-title": "Cardiovascular effects of hydroxychloroquine: a systematic review and meta-analysis", "author": "Mathieu", "doi-asserted-by": "crossref", "first-page": "e65", "journal-title": "Ann Rheum Dis", "key": "10.1016/j.nmni.2020.100747_bib39", "volume": "77", "year": "2018" }, { "author": "Farkas", "key": "10.1016/j.nmni.2020.100747_bib40", "series-title": "Myth-busting: azithromycin does not cause torsade de pointes or increase mortality. PulmCrit (EMCrit)", "year": "2015" }, { "DOI": "10.1007/s12012-014-9289-4", "article-title": "Azithromycin can prolong QT interval and suppress ventricular contraction, but will not induce torsade de pointes", "author": "Ohara", "doi-asserted-by": "crossref", "first-page": "232", "journal-title": "Cardiovasc Toxicol", "key": "10.1016/j.nmni.2020.100747_bib41", "volume": "15", "year": "2015" }, { "DOI": "10.1371/journal.pone.0200474", "article-title": "Azithromycin therapy reduces cardiac inflammation and mitigates adverse cardiac remodeling after myocardial infarction: potential therapeutic targets in ischemic heart disease", "author": "Al-Darraji", "doi-asserted-by": "crossref", "journal-title": "PLoS One", "key": "10.1016/j.nmni.2020.100747_bib42", "volume": "13", "year": "2018" }, { "author": "Swank", "key": "10.1016/j.nmni.2020.100747_bib43" }, { "DOI": "10.1046/j.1538-7836.2003.00261.x", "article-title": "Inflammation and thrombosis", "author": "Esmon", "doi-asserted-by": "crossref", "first-page": "1343", "journal-title": "J Thromb Haemost", "key": "10.1016/j.nmni.2020.100747_bib44", "volume": "1", "year": "2003" }, { "DOI": "10.1038/s41584-020-0372-x", "article-title": "Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology", "author": "Schrezenmeier", "doi-asserted-by": "crossref", "first-page": "155", "journal-title": "Nat Rev Rheumatol", "key": "10.1016/j.nmni.2020.100747_bib45", "volume": "16", "year": "2020" }, { "DOI": "10.1016/j.autrev.2014.12.006", "article-title": "Hydroxychloroquine as an antithrombotic in antiphospholipid syndrome", "author": "Belizna", "doi-asserted-by": "crossref", "first-page": "358", "journal-title": "Autoimmun Rev", "key": "10.1016/j.nmni.2020.100747_bib46", "volume": "14", "year": "2015" } ], "reference-count": 43, "references-count": 43, "relation": {}, "resource": { "primary": { "URL": "https://linkinghub.elsevier.com/retrieve/pii/S2052297520300998" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Hydroxychloroquine is protective to the heart, not harmful: a systematic review", "type": "journal-article", "volume": "37" }